Entire Transcript in Adobe Acrobat Format - National Reference ...

208
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
views differently now that we are clear about what we mean
here because we are limiting this to greater than minimal
risk nonpotentially beneficial research?
DR. EMANUEL: Well, I think there are two
separate things. One -- sorry, I misinterpreted the chart.
I apologize. I did not interpret --
MR. CAPRON: It is a fault of the chart. It is
easy --
DR. CHILDRESS: Instead of X put --
DR. EMANUEL: It is my fault. I was -- I
understand the -- let me separate it. I understand the
motivation in this category of greater than minimal risk or
no potential benefit to want higher levels of protections.
I still object or still find the idea of trying to use
advance directives -- not going to reach the objective.
What I heard from Alex and what I hear around
the table is we share the concern. We need protections for
people. The question is whether this answers that concern
and whether this is the procedure that is going to answer
that concern.
My sense, again importing some information from
other areas, is it is not going to.
Two things in response to Alex. First, I agree
end of life may not be a perfect analogy here. On the